- Home
- CCRN vs PROK Comparison
CCRN vs PROK Comparison
Compare CCRN & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCRN | PROK |
|---|---|---|
| Founded | 1986 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 315.1M | 331.2M |
| IPO Year | 2001 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CCRN | PROK |
|---|---|---|
| Price | $9.50 | $1.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $14.15 | $7.40 |
| AVG Volume (30 Days) | 547.2K | ★ 633.3K |
| Earning Date | 03-04-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $816,484,000.00 | $893,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.93 | $25.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1075.00 |
| 52 Week Low | $7.43 | $0.46 |
| 52 Week High | $15.30 | $7.13 |
Technical Indicators
Market Signals| Indicator | CCRN | PROK |
|---|---|---|
| Relative Strength Index (RSI) | 53.65 | 27.38 |
| Support Level | $7.68 | $0.54 |
| Resistance Level | $10.28 | $2.58 |
| Average True Range (ATR) | 0.40 | 0.14 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 46.49 | 0.00 |
Price Performance
Historical ComparisonAbout CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services to help health systems manage their labor ecosystem. It operates through two reportable segments: Nursing and Allied Staffing, which generates maximum revenue and provides staffing, recruiting, total talent solutions, vendor neutral programs, managed service programs, education healthcare services, caregiver services to PACE programs and outsourcing services; and Physician Staffing, which provides licensed practitioners including certified registered nurse anesthetists, nurse practitioners and physician assistants on temporary assignments. The company recruits professionals nationally and places them with healthcare facilities across the United States.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.